Causes of Elevated Liver Function Tests (LFTs)
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of elevated LFTs in developed countries, affecting 20-30% of the general population, followed by alcohol-related liver disease and chronic viral hepatitis. 1
Major Causes of Elevated LFTs
Hepatocellular Pattern (Predominant ALT/AST Elevation)
- Non-alcoholic fatty liver disease (NAFLD): Most common cause in developed countries, affecting up to 70% in obesity and 90% in diabetes 1
- Alcohol-related liver disease: Typically shows AST:ALT ratio >2 (often >3), with AST usually 2-6 times the upper limit of normal 1
- Viral hepatitis:
- Acute: Hepatitis A, B, C, D, E
- Other viral causes: EBV, CMV, HSV 1
- Drug-induced liver injury (DILI): From prescription medications, OTC drugs, herbal supplements 1
- Muscle injury/rhabdomyolysis: Can be confirmed by elevated creatine kinase (CK) 1
- Autoimmune hepatitis
- Hemochromatosis
- Wilson's disease 2
Cholestatic Pattern (Predominant ALP Elevation)
- Biliary obstruction: Gallstones, strictures, tumors
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- Drug-induced cholestasis
- Infiltrative disorders: Sarcoidosis, amyloidosis
- Malignancies: Primary or metastatic liver cancer 1
Mixed Pattern
Non-Hepatic Causes of Elevated LFTs
Elevated ALP:
- Bone disorders (Paget's disease, osteomalacia)
- Pregnancy
- Growing children
- Certain malignancies 1
Elevated AST/ALT:
- Muscle disorders
- Thyroid disorders
- Celiac disease
- Adrenal insufficiency 1
Pattern Recognition in LFT Interpretation
Hepatocellular pattern: ALT/AST elevated more than ALP
- Mild: <5× upper limit of normal
- Moderate: 5-10× upper limit of normal
- Severe: >10× upper limit of normal 1
Cholestatic pattern: ALP elevated more than ALT/AST
Mixed pattern: Both ALT/AST and ALP elevated proportionally 1
Special Considerations
Drug-Induced Liver Injury
- Many medications can cause elevated LFTs through various mechanisms
- Example: Thiazolidinediones like pioglitazone can cause rare but serious liver injury
- Monitoring recommendations for medications like pioglitazone:
- Baseline ALT before starting therapy
- Periodic monitoring during treatment
- Discontinue if ALT >3× upper limit of normal or jaundice develops 4
Genetic Factors
- Variation in LFT proteins has significant heritable basis (20-77%)
- Common environmental factors also affect most LFTs (24-54%)
- Age, sex, BMI, and alcohol use contribute significantly to inter-individual variation 5
Diagnostic Approach
First-line testing for elevated liver enzymes:
- Hepatitis serology (HBsAg, HCV antibody)
- Complete blood count with platelets
- Liver function panel
- Prothrombin time
- Creatine kinase (to rule out muscle origin) 1
Second-line testing based on initial results:
- Autoimmune markers
- Iron studies
- Ceruloplasmin
- Alpha-1 antitrypsin levels
- Additional viral serology (HEV, EBV, CMV) 1
Imaging:
- Abdominal ultrasound is first-line to assess for fatty liver, biliary obstruction, and masses
- CT or MRI for further characterization if needed 1
Common Pitfalls in LFT Interpretation
Poor predictive value of isolated LFTs: Only 3.9% of patients with abnormal values are diagnosed with significant liver disease within 5 years 1
Isolated ALP elevation: Warrants thorough investigation as 57% of cases are associated with underlying malignancy 1
Muscle injury misdiagnosis: Elevated AST/ALT can be from muscle injury rather than liver disease; check CK levels 1
Medication effects: Always review all medications, including OTC and supplements 1, 4
Normal LFTs don't exclude liver disease: Early stages of many liver diseases may present with normal LFTs 2